Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study.
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Treatment Against Human Endogenous Retrovirus: A Possible Personalized Medicine Approach for Multiple Sclerosis.
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.
Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
An observational study of venoplasty in patients with multiple sclerosis.
The progress of cognitive decline in newly diagnosed MS patients.
Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Human aquaporin 4 gene polymorphisms in Chinese patients with neuromyelitis optica.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Early-onset of multiple sclerosis in a 5-year-old girl.
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis.
Switching therapies in MS: what are the options?
[Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.
Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
Phase imaging in brain using SWIFT.
Interferon Beta and Long-term Disability in Multiple Sclerosis.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
Advances of Molecular Imaging for Monitoring the Anatomical and Functional Architecture of the Olfactory System.
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
A nine-year population-based cohort study on the risk of multiple sclerosis in patients with optic neuritis.
Pages
« first
‹ previous
…
459
460
461
462
463
464
465
466
467
…
next ›
last »